CONMED CORP (CNMD)
US2074101013 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | 64.46M | -80.60M | 62.50M | 9.50M | 28.60M | |||
| Depreciation Amortization | 71.87M | 69.60M | 70.70M | 72.60M | 72.30M | |||
| Income Taxes - Deferred | 700.00K | -6.00M | 3.00M | -14.20M | -6.30M | |||
| Change In Working Capital | -39.58M | -90.70M | -55.70M | -29.90M | -23.60M | |||
| Interest Paid | 33.69M | 26.10M | 21.80M | 30.40M | 27.30M | |||
| Taxes Paid | 19.88M | 9.10M | 8.60M | 9.10M | 10.60M | |||
| Other non cash items | 27.89M | 141.20M | 31.20M | 26.50M | 24.10M | |||
| OPERATING CASH FLOW | 125.35M | 33.40M | 111.80M | 64.50M | 95.10M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -19.03M | -21.80M | -14.90M | -13.00M | -20.10M | |||
| Other Investing Activity | -1.00M | -227.70M | N/A | -600.00K | -367.60M | |||
| INVESTING CASH FLOW | -20.03M | -249.50M | -14.90M | -13.60M | -387.70M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -88.00M | 362.00M | -81.20M | -26.30M | 362.90M | |||
| Stock Issued/Repurchased | N/A | 2.50M | N/A | 0.00 | 30.60M | |||
| Dividend Paid | -24.50M | -24.00M | -23.30M | -22.80M | -22.60M | |||
| Other Financing Activity | 2.07M | -115.50M | 3.00M | -3.00M | -69.90M | |||
| FINANCING CASH FLOW | -110.43M | 225.00M | -101.50M | -52.10M | 300.90M | |||
| Exchange Rate Effect | 470.00K | -700.00K | -1.90M | 2.70M | 0.00 | |||
| CHANGE IN CASH | -4.65M | 8.20M | -6.50M | 1.50M | 8.30M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 125.35M | 33.40M | 111.80M | 64.50M | 95.10M | |||
| Capital Expenditure | -19.03M | -21.80M | -14.90M | -13.00M | -20.10M | |||
| FREE CASH FLOW | 106.32M | 11.60M | 96.90M | 51.50M | 75.00M | |||
All data in USD